The oral therapy Jascayd (nerandomilast) has been approved in Europe for adults with idiopathic pulmonary fibrosis and ...

Columnist Sam Kirton recounts his recent 17-day stay at Inova Fairfax Hospital after receiving a diagnosis of shingles.

Not being able to help with farm chores since her pulmonary fibrosis diagnosis has been a difficult adjustment for columnist ...

The Pulmonary Fibrosis Foundation added two experienced ILD specialists to its board as it advances a five-year strategic ...

My husband, Donnie, suffered from gastroesophageal reflux disease (GERD) for several years before the onset of his lung issues, and we were surprised to learn of the connection between GERD and ...

The need for naps tends to evolve throughout one’s lifetime. When my kids were babies, it was good to let their young bodies rest midday, giving their parents a break and helping them gradually adjust ...

Vaccines based on protein fragments unique to the scar-forming cells that drive idiopathic pulmonary fibrosis (IPF) significantly reduced lung scarring in both mouse models and human cell experiments, ...

Two Phase 3 clinical trials testing Tyvaso (treprostinil) in people with idiopathic pulmonary fibrosis (IPF) both met their main goals, showing that the inhalation therapy significantly outperformed a ...

Insilico Medicine will soon launch an early clinical trial in China to test an inhaled version of its therapy candidate rentosertib in healthy volunteers and people with idiopathic pulmonary fibrosis ...

Abnormalities in DNA methylation — a type of genetic modification that can alter the activity of a gene without changing its sequence — may affect a person’s risk of developing idiopathic pulmonary ...

The U.S. Food and Drug Administration (FDA) has approved a generic version of Ofev (nintedanib) for easing lung scarring in people with idiopathic pulmonary fibrosis (IPF). The new generic nintedanib ...